Nuclear Medicine Market Report 2026

Nuclear Medicine Market Overview

• Nuclear Medicine market size has reached to $10.18 billion in 2025 • Expected to grow to $17.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Cardiovascular Disease And Cancer Surge Drive Growth In The Nuclear Medicine Market • Market Trend: Product Innovation Drives Advancements In The Nuclear Medicine Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nuclear Medicine Market?

Nuclear medicine refers to a specialised area of radiology that uses radioactive material inside the body to inspect the overall health condition of the concerned patient. The main types of nuclear medicine are diagnostic and therapeutic. A diagnostic is an examination to identify a person's distinct areas of strength and weakness to identify a condition, disease, or illness. The applications involved cardiology, lymphoma, thyroid, neurology, oncology, and other applications. The end-users included hospitals and clinics, diagnostic centers, and other end-users.

What Is The Nuclear Medicine Market Growth Forecast?

The nuclear medicine market size is expected to see rapid growth in the next few years. It will grow to $17.13 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to rising demand for advanced diagnostic and therapeutic procedures, increasing government initiatives for cancer and cardiac care, growth in hospital and diagnostic center adoption, technological advancements in radiopharmaceuticals and imaging, increasing patient awareness and healthcare expenditure. Major trends in the forecast period include rising adoption of diagnostic imaging techniques, increasing use of therapeutic radiopharmaceuticals, growing demand for pet and spect scans, rising focus on oncology and cardiology applications, increasing implementation in hospitals and diagnostic centers.

Global Nuclear Medicine Market Segmentation

1) By Type: Diagnostic, Therapeutic 2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications 3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users Subsegments: 1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras 2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents

What Is The Driver Of The Nuclear Medicine Market?

The increase in constancy and prevalence of cardiovascular disease (CVD) and cancer are expected to propel the growth of the nuclear medicine market going forward. Cardiovascular diseases (CVDs) are a group of heart and blood vessel disorders, and cancer is a disease in which cells grow out of control and spread to other body parts. Nuclear cardiac imaging can help diagnose cardiac diseases more quickly. Nuclear medicine therapy is a method to treat cancer that might be used with or after other therapy options, such as surgery and chemotherapy. As a result, the growing constancy and prevalence of cardiovascular disease and cancer increase the demand for the nuclear medicine market. For instance, in January 2023, according to the American Cancer Society Inc., a US-based non-profit health group, 1,958,310 new cancer cases are expected to be diagnosed in the US, an increase compared to more than 1,918,030 new cancer cases in 2022. Therefore, the growing constancy and prevalence of cardiovascular diseases and cancer are driving the nuclear medicine industry.

Key Players In The Global Nuclear Medicine Market

Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC

Global Nuclear Medicine Market Trends and Insights

Major companies operating in the nuclear medicine market are focusing on developing innovative solutions, such as nuclear medicine cyclotrons, to enhance the production of radiopharmaceuticals and improve diagnostic imaging capabilities. Nuclear medicine Cyclotrons are specialized particle accelerators that produce radioactive isotopes for medical imaging and therapy by directing high-energy particles at target materials, enabling the synthesis of radiopharmaceuticals used in procedures like positron emission tomography (PET). For instance, in January 2024, GE Healthcare China, a US-based medical technology company, launched its first batch of cyclotrons on December 1, 2023, at the Chengdu Tianfu International Bio-Town. These advanced particle accelerators are crucial for nuclear medicine, enabling the production of medical isotopes used in molecular imaging and therapeutic applications. This initiative aims to establish a comprehensive ecosystem for nuclear medicine, enhancing capabilities in early disease detection and personalized treatment.

What Are Latest Mergers And Acquisitions In The Nuclear Medicine Market?

In December 2023, Bristol Myers Squibb, a US-based biopharmaceutical company, acquired RayzeBio, Inc. for approximately $ 4.1 billion. Through this acquisition, BMS aims to expand its nuclear medicine oncology portfolio by integrating RayzeBio’s actinium-based radiopharmaceutical platform and advancing the development of first-in-class targeted therapies. RayzeBio, Inc. is a US-based clinical-stage company specializing in targeted radiopharmaceutical therapeutics for solid tumors.

Regional Outlook

North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nuclear Medicine Market?

The nuclear medicine market consists of sales of bone density scanning, cardiac PET perfusion, cardiac PET sarcoid. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nuclear Medicine Market Report 2026?

The nuclear medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.